ReP USP - Resultado da busca

Artigo de periodico
Melatonin-mediated actions and circadian functions that improve implantation, fetal health and pregnancy outcome (2024)
Reiter, Russel J. ; Sharma, Ramaswamy ; Chuffa, Luiz Gustavo de Almeida ; Zuccari, Debora Aparecida Pires de Campos ; Amaral, Fernanda Gaspar do ; Cipolla Neto, José
Fonte: Reproductive Toxicology. Unidade: ICB
Assuntos: FISIOLOGIA, MELATONINA, ANTIOXIDANTES, ESTRESSE OXIDATIVO, GRAVIDEZ, FETO, TROFOBLASTO, PLACENTA, PRÉ-ECLÂMPSIA, MITOCÔNDRIAS, RITMO CIRCADIANO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
REITER, Russel J. et al. Melatonin-mediated actions and circadian functions that improve implantation, fetal health and pregnancy outcome. Reproductive Toxicology, v. 124, p. 15 , 2024Tradução . . Disponível em: https://doi.org/10.1016/j.reprotox.2024.108534. Acesso em: 25 set. 2024.
APA
Reiter, R. J., Sharma, R., Chuffa, L. G. de A., Zuccari, D. A. P. de C., Amaral, F. G. do, & Cipolla Neto, J. (2024). Melatonin-mediated actions and circadian functions that improve implantation, fetal health and pregnancy outcome. Reproductive Toxicology, 124, 15 . doi:10.1016/j.reprotox.2024.108534
NLM
Reiter RJ, Sharma R, Chuffa LG de A, Zuccari DAP de C, Amaral FG do, Cipolla Neto J. Melatonin-mediated actions and circadian functions that improve implantation, fetal health and pregnancy outcome [Internet]. Reproductive Toxicology. 2024 ; 124 15 .[citado 2024 set. 25 ] Available from: https://doi.org/10.1016/j.reprotox.2024.108534
Vancouver
Reiter RJ, Sharma R, Chuffa LG de A, Zuccari DAP de C, Amaral FG do, Cipolla Neto J. Melatonin-mediated actions and circadian functions that improve implantation, fetal health and pregnancy outcome [Internet]. Reproductive Toxicology. 2024 ; 124 15 .[citado 2024 set. 25 ] Available from: https://doi.org/10.1016/j.reprotox.2024.108534
Artigo de periodico
Unveiling the complexity: liquid biopsy-based proteomic exploration of triple-negative breast cancer in women (2024)
Zuccari, Debora Aparecida Pires de Campos; Tamarindo, Guilherme; Novais, Adriana Alonso; Frigieri, Barbara Maria; Silveira, Juliano Coelho da; Souza, Fabiana Ferreira de; Labate, Carlos Alberto; Chuffa, Luis Gustavo de Almeida
Fonte: Journal of Clinical Oncology. Nome do evento: ASCO Annual Meeting. Unidades: FZEA, ESALQ
Assuntos: BIÓPSIA, NEOPLASIAS MAMÁRIAS, PROTEÔMICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ZUCCARI, Debora Aparecida Pires de Campos et al. Unveiling the complexity: liquid biopsy-based proteomic exploration of triple-negative breast cancer in women. Journal of Clinical Oncology, v. 42, n. 16 Supl., 2024Tradução . . Disponível em: https://doi.org/10.1200/JCO.2024.42.16_suppl.e13138. Acesso em: 25 set. 2024.
APA
Zuccari, D. A. P. de C., Tamarindo, G., Novais, A. A., Frigieri, B. M., Silveira, J. C. da, Souza, F. F. de, et al. (2024). Unveiling the complexity: liquid biopsy-based proteomic exploration of triple-negative breast cancer in women. Journal of Clinical Oncology, 42( 16 Supl.). doi:10.1200/JCO.2024.42.16_suppl.e13138
NLM
Zuccari DAP de C, Tamarindo G, Novais AA, Frigieri BM, Silveira JC da, Souza FF de, Labate CA, Chuffa LG de A. Unveiling the complexity: liquid biopsy-based proteomic exploration of triple-negative breast cancer in women [Internet]. Journal of Clinical Oncology. 2024 ; 42( 16 Supl.):[citado 2024 set. 25 ] Available from: https://doi.org/10.1200/JCO.2024.42.16_suppl.e13138
Vancouver
Zuccari DAP de C, Tamarindo G, Novais AA, Frigieri BM, Silveira JC da, Souza FF de, Labate CA, Chuffa LG de A. Unveiling the complexity: liquid biopsy-based proteomic exploration of triple-negative breast cancer in women [Internet]. Journal of Clinical Oncology. 2024 ; 42( 16 Supl.):[citado 2024 set. 25 ] Available from: https://doi.org/10.1200/JCO.2024.42.16_suppl.e13138
Artigo de periodico
RNA-Seq transcriptome analysis shows anti-tumor actions of melatonin in a breast cancer xenograft model (2019)
Jardim-Perassi, Bruna Victorasso; Alexandre, Pâmela Almeida ; Sonehara, Nathália Martins; Paula-Junior, Rubens de; Reis Júnior, Osvaldo; Fukumasu, Heidge ; Chammas, Roger ; Coutinho, Luiz Lehmann ; Zuccari, Debora Aparecida Pires de Campos
Fonte: Scientific Reports. Unidades: FZEA, FM, ESALQ
Assuntos: MELATONINA, SEQUÊNCIA DO DNA, NEOPLASIAS MAMÁRIAS, RNA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
JARDIM-PERASSI, Bruna Victorasso et al. RNA-Seq transcriptome analysis shows anti-tumor actions of melatonin in a breast cancer xenograft model. Scientific Reports, v. 9, n. 1, p. 1-13, 2019Tradução . . Disponível em: https://doi.org/10.1038/s41598-018-37413-w. Acesso em: 25 set. 2024.
APA
Jardim-Perassi, B. V., Alexandre, P. A., Sonehara, N. M., Paula-Junior, R. de, Reis Júnior, O., Fukumasu, H., et al. (2019). RNA-Seq transcriptome analysis shows anti-tumor actions of melatonin in a breast cancer xenograft model. Scientific Reports, 9( 1), 1-13. doi:10.1038/s41598-018-37413-w
NLM
Jardim-Perassi BV, Alexandre PA, Sonehara NM, Paula-Junior R de, Reis Júnior O, Fukumasu H, Chammas R, Coutinho LL, Zuccari DAP de C. RNA-Seq transcriptome analysis shows anti-tumor actions of melatonin in a breast cancer xenograft model [Internet]. Scientific Reports. 2019 ; 9( 1): 1-13.[citado 2024 set. 25 ] Available from: https://doi.org/10.1038/s41598-018-37413-w
Vancouver
Jardim-Perassi BV, Alexandre PA, Sonehara NM, Paula-Junior R de, Reis Júnior O, Fukumasu H, Chammas R, Coutinho LL, Zuccari DAP de C. RNA-Seq transcriptome analysis shows anti-tumor actions of melatonin in a breast cancer xenograft model [Internet]. Scientific Reports. 2019 ; 9( 1): 1-13.[citado 2024 set. 25 ] Available from: https://doi.org/10.1038/s41598-018-37413-w
Artigo de periodico
ZEB1 and ZEB2 transcription factors are potential therapeutic targets of canine mammary cancer cells (2018)
Xavier, Pedro Luiz Porfirio; Cordeiro, Yonara de Gouveia ; Rochetti, Arina Lázaro ; Sangalli, Juliano Rodrigues; Zuccari, Debora Aparecida Pires de Campos; Silveira, Juliano Coelho da ; Bressan, Fabiana Fernandes ; Fukumasu, Heidge
Fonte: Veterinary and Comparative Oncology. Unidade: FZEA
Assuntos: NEOPLASIAS MAMÁRIAS, ONCOLOGIA VETERINÁRIA, CARCINOGÊNESE ANIMAL, CÃES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
XAVIER, Pedro Luiz Porfirio et al. ZEB1 and ZEB2 transcription factors are potential therapeutic targets of canine mammary cancer cells. Veterinary and Comparative Oncology, v. 16, p. 596-605, 2018Tradução . . Disponível em: https://doi.org/10.1111/vco.12427. Acesso em: 25 set. 2024.
APA
Xavier, P. L. P., Cordeiro, Y. de G., Rochetti, A. L., Sangalli, J. R., Zuccari, D. A. P. de C., Silveira, J. C. da, et al. (2018). ZEB1 and ZEB2 transcription factors are potential therapeutic targets of canine mammary cancer cells. Veterinary and Comparative Oncology, 16, 596-605. doi:10.1111/vco.12427
NLM
Xavier PLP, Cordeiro Y de G, Rochetti AL, Sangalli JR, Zuccari DAP de C, Silveira JC da, Bressan FF, Fukumasu H. ZEB1 and ZEB2 transcription factors are potential therapeutic targets of canine mammary cancer cells [Internet]. Veterinary and Comparative Oncology. 2018 ; 16 596-605.[citado 2024 set. 25 ] Available from: https://doi.org/10.1111/vco.12427
Vancouver
Xavier PLP, Cordeiro Y de G, Rochetti AL, Sangalli JR, Zuccari DAP de C, Silveira JC da, Bressan FF, Fukumasu H. ZEB1 and ZEB2 transcription factors are potential therapeutic targets of canine mammary cancer cells [Internet]. Veterinary and Comparative Oncology. 2018 ; 16 596-605.[citado 2024 set. 25 ] Available from: https://doi.org/10.1111/vco.12427
Trabalho de evento-resumo periodico
Melatonin treatment: a transcriptomic networks in a xenograft model of breast cancer (2017)
Jardim-Perassi, Bruna Victorasso; Sonehara, Nathália Martins; Paula-Junior, Rubens de; Chammas, Roger; Coutinho, Luiz Lehmann; Reis Júnior, Osvaldo; Alexandre, Pâmela Almeida; Fukumasu, Heidge; Zuccari, Debora Aparecida Pires de Campos
Fonte: Cancer Research. Nome do evento: AACR Special Conference on Translational Control of Cancer: A New Frontier in Cancer Biology and Therapy. Unidades: FM, ESALQ, FZEA
Assuntos: EXPRESSÃO GÊNICA, MELATONINA (APLICAÇÕES TERAPÊUTICAS), NEOPLASIAS MAMÁRIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
JARDIM-PERASSI, Bruna Victorasso et al. Melatonin treatment: a transcriptomic networks in a xenograft model of breast cancer. Cancer Research. Baltimore: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://doi.org/10.1158/1538-7445.SABCS16-P1-05-28. Acesso em: 25 set. 2024. , 2017
APA
Jardim-Perassi, B. V., Sonehara, N. M., Paula-Junior, R. de, Chammas, R., Coutinho, L. L., Reis Júnior, O., et al. (2017). Melatonin treatment: a transcriptomic networks in a xenograft model of breast cancer. Cancer Research. Baltimore: Faculdade de Medicina, Universidade de São Paulo. doi:10.1158/1538-7445.SABCS16-P1-05-28
NLM
Jardim-Perassi BV, Sonehara NM, Paula-Junior R de, Chammas R, Coutinho LL, Reis Júnior O, Alexandre PA, Fukumasu H, Zuccari DAP de C. Melatonin treatment: a transcriptomic networks in a xenograft model of breast cancer [Internet]. Cancer Research. 2017 ; 77( 4):[citado 2024 set. 25 ] Available from: https://doi.org/10.1158/1538-7445.SABCS16-P1-05-28
Vancouver
Jardim-Perassi BV, Sonehara NM, Paula-Junior R de, Chammas R, Coutinho LL, Reis Júnior O, Alexandre PA, Fukumasu H, Zuccari DAP de C. Melatonin treatment: a transcriptomic networks in a xenograft model of breast cancer [Internet]. Cancer Research. 2017 ; 77( 4):[citado 2024 set. 25 ] Available from: https://doi.org/10.1158/1538-7445.SABCS16-P1-05-28
Trabalho de evento-resumo periodico
Melatonin action in xenograft model of breast cancer, comparing radiopharmaceuticals in the detection of intratumor heterogeneity by PET/CT confirmed by immunohistochemical markers (2016)
Mota, André de Lima; Jardim-Perassi, Bruna Victorasso; Borin, Thaiz Ferraz; Sonehara, Nathália Martins; Pozzo, Lorena; Bernardes, Emerson Soares; Cogliati, Bruno; Zuccari, Debora Aparecida Pires de Campos
Fonte: Cancer Research. Nome do evento: Annual Meeting of the American Association for Cancer Research. Unidade: FMVZ
Assuntos: MELATONINA, NEOPLASIAS MAMÁRIAS, TOMOGRAFIA COMPUTADORIZADA POR EMISSÃO DE PÓSITRON
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MOTA, André de Lima et al. Melatonin action in xenograft model of breast cancer, comparing radiopharmaceuticals in the detection of intratumor heterogeneity by PET/CT confirmed by immunohistochemical markers. Cancer Research. Philadelphia: American Association for Cancer Research. Disponível em: https://doi.org/10.1158/1538-7445.AM2016-2408. Acesso em: 25 set. 2024. , 2016
APA
Mota, A. de L., Jardim-Perassi, B. V., Borin, T. F., Sonehara, N. M., Pozzo, L., Bernardes, E. S., et al. (2016). Melatonin action in xenograft model of breast cancer, comparing radiopharmaceuticals in the detection of intratumor heterogeneity by PET/CT confirmed by immunohistochemical markers. Cancer Research. Philadelphia: American Association for Cancer Research. doi:10.1158/1538-7445.AM2016-2408
NLM
Mota A de L, Jardim-Perassi BV, Borin TF, Sonehara NM, Pozzo L, Bernardes ES, Cogliati B, Zuccari DAP de C. Melatonin action in xenograft model of breast cancer, comparing radiopharmaceuticals in the detection of intratumor heterogeneity by PET/CT confirmed by immunohistochemical markers [Internet]. Cancer Research. 2016 ; 76 1 .[citado 2024 set. 25 ] Available from: https://doi.org/10.1158/1538-7445.AM2016-2408
Vancouver
Mota A de L, Jardim-Perassi BV, Borin TF, Sonehara NM, Pozzo L, Bernardes ES, Cogliati B, Zuccari DAP de C. Melatonin action in xenograft model of breast cancer, comparing radiopharmaceuticals in the detection of intratumor heterogeneity by PET/CT confirmed by immunohistochemical markers [Internet]. Cancer Research. 2016 ; 76 1 .[citado 2024 set. 25 ] Available from: https://doi.org/10.1158/1538-7445.AM2016-2408

Unidades USP

ReP

Filtros

Departamento

Autores

Autores USP

Assuntos

Indexado em

Afiliação dos autores externos não normalizada